IBO (impactbiomedinc.com) Yalpi foyda bo'yicha rentabellik

impactbiomedinc.com (IBO) kompaniyasining rasmiy ramzlari

Impact BioMedical Inc (IBO) o'simliklar asosidagi tarkiblar bo'yicha patentlar tufayli biosafety segmentida o'rtacha narx belgilash imkoniyatiga ega. Valo martaba foizi operatsion samaradorlikni aks ettiradi va joriy ko'rsatkich -4026.30 ni tashkil etadi. Kompaniya o'z intellektual mulk tizimini kengaytirmoqda va 2026-yilga qadar strategik sherikliklarni rejalashtirmoqda. Biznes o'sishi 3F repellentining tijoratlashtirilishi va texnologik litsenziyalar sotuvi hisobiga ta'minlanmoqda.

impactbiomedinc.com (IBO) - Yalpi foyda bo'yicha rentabellik 17.09.2024dan 19.11.2026gacha

Impact BioMedical, Inc. (IBO) moliyaviy va bozor koʻrsatkichlari kesimi

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning asosiy tahlili:IBO Impact BioMedical, Inc.
Impact BioMedical tayyor mahsulotlari

Konservativ kapital inflyatsiyaviy zarbalarga nisbatan biznesning barqarorligini baholash uchun xarajatlar tuzilmasida shaffoflikni talab qiladi. Ushbu ko'rsatkich bevosita ishlab chiqarish xarajatlari chegirib tashlanganidan keyingi foyda marjasini o'lchaydi, bu esa xarajatlarni boshqarish samaradorligini va kompaniyaning narxlarni belgilash imkoniyatini aniqlaydi. Impact BioMedical Inc (IBO) uchun yuqori yalpi foyda marjasi patent litsenziyalash xarajatlarining pastligi va biomeditsina ishlanmalari bo'yicha royalti to'lovlarining yuqori daromadliligini tasdiqlaydi.

Asosiy raqobatchilar

Yalpi foyda marjasi Haleon PLC (HLN)|Yalpi foyda bo'yicha rentabellik KVUE|Yalpi foyda marjasi Verona Pharma Inc. VRNA|Yalpi marja MENS|Ligand Pharmaceuticals - Sotuvning yalpi rentabelligi|Yalpi rentabellik Amneal AMRX|Sotuvning yalpi marjinal rentabelligi Perrigo Company PLC|Alvotech Biopharmaceuticals - Yalpi marja|Yalpi foyda bo'yicha sotuv rentabelligi Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Yalpi rentabellik|anipharmaceuticals.com - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik MNKD|AMPH: Yalpi foyda normasi|Yalpi rentabellik pacira.com (PCRX)|Yalpi marja ARS Pharma (SPRY)|Theravance Biopharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda koeffitsiyenti AQST (Aquestive Therapeutics)|SCPH: Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi Tectonic Therapeutic|TNXP: Yalpi marja|SXT China (SXTC) - Yalpi marja|Yalpi rentabellik eupraxiapharma.com|BioHarvest Sciences (BHST) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Invizyne (EXOZ)|ORMP - Yalpi foyda marjasi|Yalpi marja ENTX (Entera Bio)|Sotuvning yalpi marjinal rentabelligi MindWalk Therapeutics|ABVC: Yalpi foyda bo'yicha rentabellik|CPIX - Yalpi marja|QNTM (Quantum BioPharma) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha marjinallik FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Yalpi marja|Yalpi marja ranitherapeutics.com|Yalpi rentabellik Synergy CHC Corp. (SNYR)|Rallybio Corp - Sotuvning yalpi rentabelligi|lexariabioscience.com - Yalpi foyda bo'yicha rentabellik|Yalpi marja Pulmatrix Inc PULM|Pheton Holdings - Yalpi marja|Yalpi foyda bo'yicha marjinallik APM|Lyra Therapeutics, Inc. (LYRA) - Yalpi rentabellik|TNF Pharma (TNFA) - Yalpi marja|YCBD (cbdmd.com) - Yalpi marja|Yalpi foyda bo'yicha rentabellik PainReform (PRFX)|Yalpi rentabellik Altamira Therapeutics (CYTO)|Yalpi foyda bo'yicha sotuv rentabelligi Lipella Pharma|Optinose - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi pieris.com (PIRS)|PROC - Yalpi rentabellik|Yalpi foyda bo'yicha marjinallik PTPI|QLI: Yalpi marja|Yalpi foyda marjasi ACELYRIN Inc. (SLRN)|TFFP (TFF Pharmaceuticals, Inc) - Yalpi marja